close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

Antibiotics Over-prescribed for Strep

November 11, 2005

To prescribe or not to prescribe? About 50% of children who present with a sore throat receive antibiotics from their doctor- although at least two-thirds of the cases are likely to have a viral, rather than bacterial, origin, according to a new study.

Equally unsettling, only about half of physicians do a throat culture before giving children antibiotics for a sore throat, despite strong recommendations that children be tested for group A beta-hemolytic streptococci, according to a report by Jeffrey A Linder, MD, MPH, of Harvard Medical School and colleagues.

The report by Linder et al was published in the 9 November issue of the Journal of the American Medical Association and reported by MedPage Today on 9 November 2005.

The American Academy of Pediatrics, the Centers for Disease Control and Prevention (CDC), and the Infectious Disease Society of America recommend testing for group A beta-hemolytic streptococci, according to MedPage Today.

Study Results

In a review of data from national ambulatory care surveys conducted during the period 1995-2003, Dr Linder et al found that, during approximately 7.3 million annual visits for sore throat, doctors prescribed antibiotics in about 53% of cases. This percentage is considerably higher than the 15-36% prevalence of strep throat.

Moreover, about 50% of children who received antibiotics got the wrong drugs, or a non-recommended drug (27%). Recommended agents include amoxicillin, penicillin, first-generation cephalosporins and erythromycin.

Antibiotics not recommended but often prescribed include other cephalosporins, extended spectrum macrolides (e.g., Zithromax [azithromycin], Biaxin [clarithromycin]), Augmentin [amoxicillin-clavulanate]) or other agents.

"Encouragingly, we found a significant decrease in the proportion of patients receiving antibiotics over the study period," Dr Linder and colleagues wrote. "However, even at the end of the study period, the proportion of children prescribed an antibiotic still exceeded the maximum expected prevalence of group A beta-hemolytic streptococci among children with sore throat."

Doctors performed a group A beta-hemolytic streptococci test in 53% of visits, and in 51% of visits at which they prescribed an antibiotic. Group A beta-hemolytic streptococci testing was not associated with a lower prescribing rate of antibiotics (48% tested versus 51% not tested), but testing was associated with a lower antibiotic prescribing rate for children with a diagnosis of pharyngitis, tonsillitis and streptococcal sore throat (57% tested versus 73% not tested).

Interestingly, the clinical setting where the children were seen made a difference. Non-pediatrician, primary-care doctors and emergency department staff were about half as likely to test for group A beta-hemolytic streptococci as pediatricians, and they were about 60% more likely to prescribe an antibiotic. However, children seen in emergency departments were less likely to get a non-recommended drug.

The results of the study suggest that, although a downward trend in prescribing antibiotics exists, children are still needlessly receiving antibiotics, the authors contended.

"Perhaps unique among upper respiratory tract infections, clinicians have good, objective criteria in the form of group A beta-hemolytic streptococci testing to guide the antibiotic treatment of children with sore throat," Dr Linder and colleagues wrote. "Limiting antibiotic prescribing to children with a positive group A beta-hemolytic streptococci test result is a feasible goal for primary care physicians and an important step toward judicious use of antibiotics overall."

In accompanying editorial, J Todd Weber, MD, of the Office of Antimicrobial Resistance at the CDC's National Center for Infectious Diseases in Atlanta concurred with the researchers.

"To ensure appropriate use of antimicrobial drugs, the issue must be addressed across all diseases and all sectors of society," Dr Weber wrote. "Failure to do so will result in wasting the valuable resource of effective antimicrobial agents-a resource that still could be preserved for some time to come."

Sources:
Strep or No, Half of Kids Get Antibiotics for Sore Throat, MedPageToday, 8 November 2005.
Appropriate Use of Antimicrobial Drugs: A Better Prescription Is Needed, J. Todd Weber, MD, Journal of the American Medical Association, volume 294, pages 2354-2356, 9 November 2005.

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 24, 2008
Audience: Infectious disease and medical genetics healthcare professionals[Posted 07/24/2008] FDA informed healthcare...
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...